JD Health Valuation
| JDHIY Stock | USD 3.81 0.00 0.00% |
At this time, the firm appears to be overvalued. JD Health International owns a latest Real Value of $3.66 per share. The recent price of the firm is $3.81. Our model calculates the value of JD Health International from inspecting the firm fundamentals such as Operating Margin of (0.02) %, revenue of 30.68 B, and Return On Asset of -0.0099 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that JD Health's price fluctuation is slightly risky at this time. Calculation of the real value of JD Health International is based on 3 months time horizon. Increasing JD Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since JD Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of JDHIY Pink Sheet. However, JD Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.81 | Real 3.66 | Hype 3.81 |
The intrinsic value of JD Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence JD Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of JD Health International helps investors to forecast how JDHIY pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of JD Health more accurately as focusing exclusively on JD Health's fundamentals will not take into account other important factors: JD Health Total Value Analysis
JD Health International is currently forecasted to have takeover price of 29.92 B with market capitalization of 24.62 B, debt of 194.3 M, and cash on hands of 45.68 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the JD Health fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.92 B | 24.62 B | 194.3 M | 45.68 B |
JD Health Investor Information
The book value of the company was currently reported as 13.33. The company recorded a loss per share of 0.05. JD Health International had not issued any dividends in recent years. JD Health International is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.JD Health Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of JDHIY suggests not a very effective usage of assets in December.JD Health Profitability Analysis
The company reported the revenue of 30.68 B. Net Loss for the year was (1.07 B) with profit before overhead, payroll, taxes, and interest of 7.2 B.About JD Health Valuation
Our relative valuation model uses a comparative analysis of JD Health. We calculate exposure to JD Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of JD Health's related companies.JD Health International Inc., an investment holding company, operates an online healthcare platform in the Peoples Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited. Jd Health is traded on OTC Exchange in the United States.
8 Steps to conduct JD Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates JD Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct JD Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain JD Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine JD Health's revenue streams: Identify JD Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research JD Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish JD Health's growth potential: Evaluate JD Health's management, business model, and growth potential.
- Determine JD Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate JD Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
JD Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.2 B | |
| Forward Price Earnings | 185.1852 | |
| Retained Earnings | -19.7 B |
Additional Tools for JDHIY Pink Sheet Analysis
When running JD Health's price analysis, check to measure JD Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JD Health is operating at the current time. Most of JD Health's value examination focuses on studying past and present price action to predict the probability of JD Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JD Health's price. Additionally, you may evaluate how the addition of JD Health to your portfolios can decrease your overall portfolio volatility.